FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Dyslipidemia
• Familial Combined Hyperlipidemia
• Hyperlipidemia
• Hypertriglyceridemia
• Mixed Dyslipidemia

Drugs mentioned

• LIPOFEN (FENOFIBRATE)

Snippet

SUPPL AP for LIPOFEN (FENOFIBRATE)